1. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT, Neonatal Diabetes International Collaborative Group (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355(5):467–477
2. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53(12):2504–2508
3. Flanagan SE, Kapoor RR, Hussain K (2011) Genetic of congenital hyperinsulinemic hypoglycemia. Semin Pediatr Surg 20(1):13–17
4. Ellard S, Lango Allen H, De Franco E, Flanagan SE, Hysenaj G, Colclough K, Houghton JA, Shepherd M, Hattersley AT, Weedon MN, Caswell R (2013) Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia 56(9):1958–1963
5. Ellard S, Shields B, Tysoe C, Treacy R, Yau S, Mattocks C, Wallace A (2009) Semi-automated unidirectional sequence analysis for mutation screening in a clinical diagnostic setting. Genet Test 13(3):381–386